scholarly journals Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis

2018 ◽  
Vol 2018 (11) ◽  
Author(s):  
Takehiro Tozuka ◽  
Teppei Sugano ◽  
Rintaro Noro ◽  
Natsuki Takano ◽  
Kakeru Hisakane ◽  
...  
Keyword(s):  
Interstitial Lung Disease ◽  
Myasthenia Gravis ◽  
Lung Disease ◽  
Pleomorphic Carcinoma ◽  
Ocular Myasthenia ◽  
Carcinoma Patient ◽  
Ocular Myasthenia Gravis

Abstract #1154: Ocular Myasthenia Gravis in the Setting of Graves’ Disease

2016 ◽  
Vol 22 ◽  
pp. 277-278
Author(s):  
Lima Lawrence ◽  
Aleida Rodriguez ◽  
Tahira Yasmeen ◽  
Erin Drever
Keyword(s):  
Myasthenia Gravis ◽  
Graves Disease ◽  
Ocular Myasthenia ◽  
Ocular Myasthenia Gravis

The diagnosis and management of ocular myasthenia gravis

2019 ◽  
Vol 5 (1-2) ◽  
pp. 3-8
Author(s):  
Gordon Plant
Keyword(s):  
Myasthenia Gravis ◽  
Severe Form ◽  
Differential Diagnostics ◽  
Diagnosis And Management ◽  
Ocular Myasthenia ◽  
Clinical Presentations ◽  
Ocular Myasthenia Gravis

Ocular myasthenia is not the most severe form of myasthenia but it might cause certain difficulties to diagnose. In this article, we shall discuss the clinical presentations of ocular myasthenia, its differential diagnostics, examinations and management. Keywords: ocular myasthenia gravis, diagnosis, examination, management.

Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort

2021 ◽  
Vol 118 ◽  
pp. 12-19
Author(s):  
Kristen S. Fisher ◽  
Jason Gill ◽  
Hannah F. Todd ◽  
Michael B. Yang ◽  
Michael A. Lopez ◽  
...  
Keyword(s):  
Myasthenia Gravis ◽  
Treatment Outcomes ◽  
Large Cohort ◽  
Ocular Myasthenia ◽  
Ocular Myasthenia Gravis

Interobserver and Intra-Observer Reliability of Eyelid Tests for Ocular Myasthenia Gravis

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Thanchat Jienmaneechotchai ◽  
Supanut Apinyawasisuk ◽  
Supharat Jariyakosol ◽  
Parima Hirunwiwatkul
Keyword(s):  
Myasthenia Gravis ◽  
Ocular Myasthenia ◽  
Observer Reliability ◽  
Ocular Myasthenia Gravis

Tobramycine eye drops and ocular myasthenia gravis reactivation: A case report

Therapies ◽  
2020 ◽  
Author(s):  
Claire de Canecaude ◽  
Christophe Gazagne ◽  
Magali Paraire ◽  
Geneviève Durrieu
Keyword(s):  
Case Report ◽  
Myasthenia Gravis ◽  
Eye Drops ◽  
Ocular Myasthenia ◽  
Ocular Myasthenia Gravis

Ptosis and Neuromuscular Syndromes

2014 ◽  
pp. 83-119
Author(s):  
Shirley H. Wray
Keyword(s):  
Myasthenia Gravis ◽  
Neuromuscular Transmission ◽  
Clinical Importance ◽  
Progressive External Ophthalmoplegia ◽  
Oculopharyngeal Muscular Dystrophy ◽  
Fisher Syndrome ◽  
Ocular Myasthenia ◽  
Kearns Sayre Syndrome ◽  
Ocular Myasthenia Gravis

emphasizes the clinical importance of a careful patient history detailing the onset of ptosis, its variability, and its progression. A pattern of ocular and generalized muscle weakness is a central diagnostic attribute of impaired nerve conduction due to disease of the neuromuscular junction. Generalized myasthenia gravis, ocular myasthenia gravis, MuSK-myasthenia gravis, and a case of the Lambert-Eaton syndrome illustrate the spectrum of disorders of neuromuscular transmission. The syndrome known as chronic progressive external ophthalmoplegia is by far the most common of the mitochondrial myopathies progressing to the multisystem failure that is characteristic of the Kearns-Sayre syndrome. A case of Kearns-Sayre syndrome followed for 34 years is a unique case study. Two inherited forms of myopathy, oculopharyngeal muscular dystrophy and myotonic dystrophy, are included, together with a patient with the Guillain-Barré syndrome variant, Fisher syndrome. These disorders should always be considered in the differential diagnosis of bilateral progressive ptosis.

Sign in / Sign up

Export Citation Format

Share Document